Liang, N.* et al. Peripheral metabolism informs on future cognitive decline and development of Alzheimer’s disease in population at risk. Alzheimers Dement. 20, 1:e089802 (2025)
Luan, Y.* et al. Multimodal spatial gradients to explain regional susceptibility to fibrillar tau in Alzheimer's disease. Alzheimers Dement. 21:e70170 (2025)
Wagemann, O.* et al. Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's disease. Alzheimers Dement. 21:e70040 (2025)
Arnold, M. Integrating multi-omics data for target and biomarker discovery. In:. 2024.:e086331 (Alzheimers Dement. ; 20 Suppl 1)
Batra, R.* et al. Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy. Alzheimers Dement., DOI: 10.1002/alz.14249 (2024)
Batra, R.* et al. Central and Peripheral Biochemical Changes in Alzheimer’sDisease: Insights from the Alzheimer Disease MetabolomicsConsortium. In:. 2024.:e092421 (Alzheimers Dement. ; 20 Suppl 2)
Fish, L.A.* et al. A cognitive resilience gene expression signature in excitatory intratelencephalic cortical neurons. In:. 2024.:e095063 (Alzheimers Dement. ; 20 Suppl 8)
Hüper, L.* et al. Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers. Alzheimers Dement., DOI: 10.1002/alz.13863 (2024)
MahmoudianDehkordi, S.* et al. Metabolomics Analysis of the MIND Study Informs about Metabolic 
Benefit and Heterogeneity among Individuals‐ A Precision Medicine 
Approach for Diet Interventions. In:. 2024.:e089899 (Alzheimers Dement. ; 20 Suppl 2)
Pandey, R.S.* et al. Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.13851 (2024)
Schweickart, A.* et al. A Modified Mediterranean Ketogenic Diet reverses signaturesand mitigates modifiable risk factors of Alzheimer’s disease. In:. 2024.:e089878 (Alzheimers Dement. ; 20 Suppl 7)
Telpoukhovskaia, M.A.* et al. New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshop. Alzheimers Dement. 10:e12458 (2024)
Arnold, M. et al. Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease. Poster: Basic Science and Pathogenesis – Part 1 (2023)
Batra, R.* et al. The landscape of metabolic brain alterations in Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.12714 (2022)
Labus, J.S.* et al. Interactions between brain and bile acid ratio profiles predict baseline cognitive status. Alzheimers Dement. 18:e067272 (2022)
Oeckl, P.* et al. Relationship of serum beta-synuclein with blood biomarkers and brain atrophy. Alzheimers Dement. 19, 1358-1371 (2022)
van Duijn, C.M.* et al. Interplay of the human exposome, metabolome and gut microbiome in dementia and major depression. Alzheimers Dement. 18:e067261 (2022)
Wang, T.* et al. APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimers Dement. 18, 2151-2166 (2022)
Wörheide, M. ; Krumsiek, J.* ; Kastenmüller, G. ; Kaddurah-Daouk, R.F.* & Arnold, M. A proof of concept study towards multi-omics-based computational drug repositioning in Alzheimer's disease. Alzheimers Dement. 17, 3:e056673 (2022)
Baloni, P.* et al. Investigating the importance of acylcarnitines in Alzheimer's disease. Alzheimers Dement. 17:e056647 (2021)
Horgusluoglu, E.* et al. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.12468 (2021)
Chandupatla, R.R.* ; Flatley, A. ; Feederle, R. ; Mandelkow, E.M.* & Kaniyappan, S.* Novel antibody against low-n oligomers of tau protein promotes clearance of tau in cells via lysosomes. Alzheimers Dement. 6:e12097 (2020)
Kling, M.A.* et al. Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau. Alzheimers Dement. 16, 1234-1247 (2020)
Barupal, D.K.* et al. Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology. Alzheimers Dement. 11, 619-627 (2019)
Nho, K.* et al. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement. 15, 232-244 (2019)
MahmoudianDehkordi, S.* et al. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement. 15, 76-92 (2018)
Ovsepian, S.V. ; O'Leary, V.B. ; Zaborszky, L.* ; Ntziachristos, V. & Dolly, O.J.* Synaptic vesicle cycle and amyloid beta: Biting the hand that feeds. Alzheimers Dement. 14, 502-513 (2018)
Toledo, J.B.* et al. Metabolic network failures in Alzheimer's disease-A biochemical road map. Alzheimers Dement. 13, 965-984 (2017)